202 related articles for article (PubMed ID: 18478553)
21. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
22. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils.
Spinner DS; Kascsak RB; Lafauci G; Meeker HC; Ye X; Flory MJ; Kim JI; Schuller-Levis GB; Levis WR; Wisniewski T; Carp RI; Kascsak RJ
J Leukoc Biol; 2007 Jun; 81(6):1374-85. PubMed ID: 17379700
[TBL] [Abstract][Full Text] [Related]
23. Prion inactivation by the Maillard reaction.
Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
[TBL] [Abstract][Full Text] [Related]
24. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
26. Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts.
Russelakis-Carneiro M; Hetz C; Maundrell K; Soto C
Am J Pathol; 2004 Nov; 165(5):1839-48. PubMed ID: 15509552
[TBL] [Abstract][Full Text] [Related]
27. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
28. Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage.
Béranger F; Crozet C; Goldsborough A; Lehmann S
Biochem Biophys Res Commun; 2008 Sep; 374(1):44-8. PubMed ID: 18602368
[TBL] [Abstract][Full Text] [Related]
29. Copaxone interferes with the PrP Sc-GAG interaction.
Engelstein R; Ovadia H; Gabizon R
Eur J Neurol; 2007 Aug; 14(8):877-84. PubMed ID: 17662008
[TBL] [Abstract][Full Text] [Related]
30. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
[TBL] [Abstract][Full Text] [Related]
31. Generation of antisera to purified prions in lipid rafts.
Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
Prion; 2010; 4(2):94-104. PubMed ID: 20647769
[TBL] [Abstract][Full Text] [Related]
32. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of a protein misfolding cyclic amplification for PrPSc].
Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
35. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
36. The number of octapeptide repeat affects the expression and conversion of prion protein.
Hiraga C; Kobayashi A; Kitamoto T
Biochem Biophys Res Commun; 2009 May; 382(4):715-9. PubMed ID: 19318088
[TBL] [Abstract][Full Text] [Related]
37. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
38. Computerized morphometric analysis of pathological prion protein deposition in scrapie-infected hamster brain.
Maximova OA; Taffs RE; Pomeroy KL; Piccardo P; Asher DM
J Histochem Cytochem; 2006 Jan; 54(1):97-107. PubMed ID: 16148313
[TBL] [Abstract][Full Text] [Related]
39. Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.
Rambold AS; Miesbauer M; Olschewski D; Seidel R; Riemer C; Smale L; Brumm L; Levy M; Gazit E; Oesterhelt D; Baier M; Becker CF; Engelhard M; Winklhofer KF; Tatzelt J
J Neurochem; 2008 Oct; 107(1):218-29. PubMed ID: 18691383
[TBL] [Abstract][Full Text] [Related]
40. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
Filesi I; Cardinale A; Mattei S; Biocca S
J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
